Objective: To explore the influence of the different timing of percutaneous coronary intervention on plasma MMP and Ps in acute myocardial infarction patients with aneurysm. Methods: 210 cases of acute myocardial infarction patients with aneurysm from March 2010 to March 2016 in our hospital were selected as the research objects and divided into group A(25 cases,<3 h), group B(67 cases, 6 h ≤ and<12 h), group C(88 cases, 6 h ≤ and<12 h) and group D(≥ 12 h and<1week;30 cases),according to the time accepting PCI.Associated parameters of left ventricular systolic and diastolic function in patients and PVI were measured by left ventricle angiography and echocardiography at the baseline and 6 months after PCI.The level of MMP-9 and Ps were measured at different times before and after the PCI.3-years follow-up was finished after PCI, and MACE were recorded. Results: 6 months after PCI, PS and FWHM in groups A, B, C were significantly lower than those in group D, while LVEF was higher in groups A, B, C(P<0.05); in the 6th month after PCI, the PVI was significantly lower in group A(12.5±2.8)% than in groups B(15.8±3.3)%, C(15.5±3.1)%, D(20.9±3.7)%(P<0.05); The level of MMP-9 and Ps at 3 d, 7 d after myocardial infarction was significantly lower in group A than in group D(P<0.05); while no significant difference was found between group C and group D; Within the 3-years follow-up, the incidence of MACE and the mortality were significantly lower in groups A, B, C than in group D(P<0.05). Conclusion: In patients with acute myocardial infarction received early coronary intervention, recanalization of the infarct artery can effectively reverse the left ventricular aneurysm formation, and decrease the MMP-9 and P selectin, improve cardiac function and prognosis of patients. |
[1] SONG P S.Spironolactone lowers the rate of repeat revascularization in acute myocardial infarction patients treated with percutaneous coronary intervention[J].Am Heart J,2014,168(3):346-353.
[2] MORI M,SAKAKURA K,WADA H,et al.Left ventricular apical aneurysm following primary percutaneous coronary intervention[J].Heart & Vessels,2012,28(6):677-683.
[3] 胡晓峰,杨明,李贵森,等.冠脉介入术对急性心肌梗死患者血浆CRP、MMP-9及P选择素浓度的影响[J].宁夏医科大学学报,2015,37(5):591-593.
[4] 饶志荣,方快发,刘文兵,等.急性ST段抬高型心肌梗死介入治疗对脑利钠肽及心室重构的影响[J].海南医学,2013,24(7):946-948.
[5] 高润霖.急性心肌梗死诊断和治疗指南[J].中华心血管病杂志,2001,29(12):710-725.
[6] 中华医学会心血管病学分会介入心脏病学组,中国医师协会心血管内科医师分会血栓防治专业委员会,中华心血管病杂志编辑委员会,等.中国经皮冠状动脉介入治疗指南(2016)[J].中华心血管病杂志,2016,44(5):382-400.
[7] 杨跃进,杨进刚.AHA/ACC 2009年ST段抬高心肌梗死和经皮冠状动脉介入治疗指南更新解读[J].心血管病学进展,2010,31(2):159-161.
[8] 张明明,徐延玲,王孝福,等.瑞舒伐他汀对不稳定型心绞痛患者经皮冠状动脉介入治疗后心肌损伤标志物、炎性因子及可溶性P选择素的影响研究[J].实用心脑肺血管病杂志,2016,24(2):12-15.
[9] 孙飞,刘长青,胡高频,等.急性前壁心肌梗死患者发病至经皮冠状动脉介入治疗时间对基质金属蛋白酶和左心室重构的影响[J].中华老年医学杂志,2015,34(9):939-942.
[10] 唐念中,陈少萍,王君,等.不同剂量ASA对PCI术后患者血浆TXB2和P选择素水平的影响[J].现代生物医学进展,2014,14(25):4869-4872.
[11] 翟虹,王春梅,穆玉明,等.室壁瘤形成过程中基质金属蛋白酶-9与心功能及室壁瘤容积相关性研究[J].重庆医学,2015,44(32):4487-4489.
[12] 吴鹏翠,阳军,陈然,等.NT-proBNP和MMP-9与急性心肌梗死患者早期左室重构的相关性研究[J].医学临床研究,2015,32(3):540-542.
[13] 孙飞,刘长青,胡高频,等.急性前壁心肌梗死患者发病至经皮冠状动脉介入治疗时间对基质金属蛋白酶和左心室重构的影响[J].中华老年医学杂志,2015,34(9):939-942.
[14] 王裕勤,吴佳源,段世英,等.不同时间窗急诊冠状动脉介入治疗对急性ST段抬高心肌梗死患者预后的比较[J].临床内科杂志,2016,33(6):410-412.
[15] KOROSOGLOU G,HAARS A,HUMPERT P M,et a1.Evaluation of myocardial perfusion and deformation in patients with acute myocardial infarction treated with primary angioplasty and stent placement[J].Coronary Artery Dis,2008,19(7):497-506.
[16] 刘俭雄,石理,李军,等.急性心肌梗死PCI治疗后血清基质金属蛋白酶9、C反应蛋白、P选择素的变化及意义[J].山东医药,2016,56(5):64-65. |